Navigation Links
Screening For Prostate Cancer in men over 75 Questioned

The prostate specific antigen test is a convenient and relatively inexpensive way for early detection of prostate cancer. While efficacy of PSA is controversial in younger men, doctors say there is a general consensus that the test //should not be given to men over 75. Despite this, a new study finds many physicians are suggesting and doing a PSA test on older men.

The decision to not screen older men with a PSA test is because the life expectancy without the test is nearly identical to men who have the test and undergo therapy for prostate cancer. Researchers reviewed information from a previous study to see who was initiating the idea and if physicians are discussing the risks and benefits of a PSA screening with patients before testing.

The study included information from 7,889 men who participated in a previous survey. Researchers report 32.5 percent of the men 75 years or older said they had a PSA screening during the last year. Among the men who had the test, 88.4 percent say their doctor suggested the screening and 66.5 percent reported having a discussion about the advantages and disadvantages of the test with their doctor before the screening was done.

Researchers say it is somewhat surprising so many physicians would suggest a screening in an elderly patient and they also say that the Ultimate, decision regarding the appropriateness of PSA screening in elderly men and the allocation of health care resources will have to be made by patients, physicians, and society working together. They say information about how patients and physicians interpret medical data on the PSA screening is critical to understanding the risks and benefits of this test in elderly men.
'"/>




Page: 1

Related medicine news :

1. Screening device for ovarian cancer
2. Screening bypasses radical breast surgery
3. Screening of Lazy Eye
4. Screening Cost-Effective for Lung Cancer
5. Screening Newborns Questioned
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. The Effectiveness Of Screening Tests Questioned
8. Screening Test For Early Diagnosis Of Colorectal Cancer
9. The Importance Of Skin Cancer Screening
10. Ovarian Cancer Screening Questioned
11. Early Screening Required for Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
Breaking Medicine Technology: